Clinical Trial

Delegation of International Communication Experts and Foreign Media Outlets Visits Emerging Industry Enterprises in Zhongshan, Guangdong Province

BEIJING, Oct. 10, 2024 /PRNewswire/ -- On October 9, 2024, the delegation of international communication experts and foreign media outlets,…

1 year ago

ObvioHealth Announces the Appointment of Nicholas Campbell to Its Board of Directors

Seasoned Healthcare Executive Nicholas Campbell Joins ObvioHealth Board of Directorsto Drive Digital Innovation in Clinical Trials NEW YORK, Oct. 10,…

1 year ago

Microsoft expands AI capabilities to shape a healthier future

REDMOND, Wash., Oct. 10, 2024 /PRNewswire/ -- On Thursday, Microsoft Corp. is unveiling several Microsoft Cloud for Healthcare innovations that…

1 year ago

Dynocardia’s Direct Continuous Blood Pressure Monitoring Technology Receives Grant from NIH’s Commercialization Readiness Pilot Program

The grant, which is awarded to companies developing significantly impactful technologies with the potential to change clinical practice, will support…

1 year ago

Movano Health Provides Update on FDA Review of EvieMED Ring

The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif., Oct.…

1 year ago

Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders Strategic Partnership: Streamlined, single-vendor…

1 year ago

International Myeloma Foundation Launches Clinical Trial Matching Engine in Partnership with SparkCures

SparkCures’ best-in-class clinical trial matching and navigation service is now accessible via myeloma.org.STUDIO CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE)…

1 year ago

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the…

1 year ago

Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics

DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company…

1 year ago

Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program

Company’s VP of Education and Global Training Named Chairman of ASRM Corporate Member CouncilATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) --…

1 year ago